Received Feb 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 5A4H7 | — |
skin rash all over his body and itching; This non-serious case was reported by a consumer via call center representative and described the occurrence of itchy rash in a elderly male patient who received Herpes zoster (Shingrix) (batch number 5A4H7, expiry date 31-OCT-2026) for prophylaxis. On 01-NOV-2024, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced itchy rash (Verbatim: skin rash all over his body and itching). The outcome of the itchy rash was not resolved. It was unknown if the reporter considered the itchy rash to be related to Shingrix. It was unknown if the company considered the itchy rash to be related to Shingrix. Additional Information: GSK Receipt Date: 21-JAN-2025 The patient received Shingrix and within a couple of days of receiving the second dose, he had a skin rash all over his body and itching. The patient reported that he continued to have the rash and itching today (date of reporting), but not as severe.